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The processes that determine an organism’s lifespan are
complex and poorly understood. Yet single gene manipu-
lations and environmental interventions can substantially
delay age-related morbidity. In this review, we focus on
the two most potent modulators of longevity: insulin/
insulin-like growth factor 1 (IGF-1) signaling and dietary
restriction. The remarkable molecular conservation of
the components associated with insulin/IGF-1 signaling
and dietary restriction allow us to understand longevity
from a multi-species perspective. We summarize the
most recent findings on insulin/IGF-1 signaling and
examine the proteins and pathways that reveal a more
genetic basis for dietary restriction. Although insulin/
IGF-1 signaling and dietary restriction pathways are
currently viewed as being independent, we suggest that
these two pathways are more intricately connected than
previously appreciated. We highlight that numerous inter-
actions between these two pathways can occur at multiple
levels. Ultimately, both the insulin/IGF-1 pathway and the
pathway that mediates the effects of dietary restriction
have evolved to respond to the nutritional status of an
organism, which in turn affects its lifespan.
Introduction
Aging is a nearly universal process that involves the progres-
sive deterioration of metabolic, muscular, reproductive, and
cognitive functions, which ultimately affects lifespan [1]. In
addition, in humans, the onset of several debilitating dis-
eases that could potentially reduce overall lifespan — such
as type II diabetes, cancer, and heart disease — is associ-
ated with the aging process. A complex array of genetic
and environmental factors plays an important role in modu-
lating lifespan. Studies in the past two decades have focused
on elucidating the genetic determinants of longevity, using
approaches such as genome-wide RNA interference (RNAi)
and mutagenesis screens, microarrays, and protein arrays
[2–5]. This work has led to the identification of several impor-
tant genes across phylogeny that are involved in diverse
cellular processes, including development, mitochondrial
function, energy metabolism, protein translation, and the
cell cycle.
The insulin/IGF-1 signaling pathway and modulation of
food intake by dietary restriction have the most robust effects
on lifespan across species. Insulin/IGF-1 signaling is a well-
conserved and well-defined pathway that has been shown
to regulate longevity in the nematode Caenorhabditis ele-
gans, the fruitfly Drosophila melanogaster, and in several
rodent models [6]. In contrast, dietary restriction was long
thought of as an extrinsic intervention manifesting in
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Dietary restriction, where the actual number of calories in-
gested by the animal is unknown, differs from caloric restric-
tion, where the exact number of calories consumed is known
and the food is also supplemented with extra nutrients such
as vitamins and minerals to prevent malnutrition. Recent
studies have identified several genes that are necessary for
lifespan extension mediated by dietary restriction, suggest-
ing that, like insulin/IGF-1 signaling, the longevity-inducing
effects of dietary restriction may be regulated by well-defined
pathways [7–9].
In this review, we examine the insulin/IGF-1 signaling
pathway and genetic components that are required for
increased lifespan in response to dietary restriction. It is
not entirely clear whether insulin/IGF-1 signaling and dietary
restriction are independent, given that they are both major
regulators of lifespan across phylogeny. We discuss the
potential cross-talk between these pathways at multiple
levels, and we suggest that the preferred pathway to ulti-
mately control longevity may depend upon the nutritional
status of the organism. The role of specific cell types and
tissues as well as the spatio-temporal expression of genes
involved in insulin/IGF-1 signaling and dietary restriction
are undoubtedly important for understanding the regulation
of lifespan. We refer the reader to some excellent reviews
that discuss this aspect further [4,10].
Insulin/IGF-1 Signaling
Initial studies in C. elegans identified single gene mutations
that resulted in a profound extension in lifespan [2,6]. Further
genetic epistasis analysis showed that these genes, age-1
and daf-2, were part of the same genetic pathway [2,6,11,12].
Subsequent cloning studies identified the daf-2 gene as
being equally homologous to both the mammalian insulin
and the mammalian IGF-1 receptors and age-1 as being
homologous to the worm phosphoinositide (PI) 3-kinase
catalytic subunit, thus revealing a C. elegans insulin/IGF-1
signaling pathway [2,6]. Since then the insulin/IGF-1 sig-
naling pathway has emerged as the most well-characterized
regulator of longevity across species. Indeed, no pathway
has been identified with a more pronounced effect on
longevity [2,6,13]. Furthermore, the components of insulin/
IGF-1 signaling show remarkable molecular conservation
from worms to humans (Table 1) and several studies have
found a correlation between naturally occurring polymor-
phisms in this pathway and human longevity [6,14–16].
Insulin-Like Peptides and the Insulin/IGF-1 Signaling
Pathway
At the cellular level, it is well-established that changes in
blood glucose levels are the main trigger for insulin secretion
in mammals. Similarly, in the context of the macroenviron-
ment, organisms constantly sense their surroundings. In
C. elegans, depending upon the availability of nutrients,
several olfactory and chemosensory neurons are thought
to regulate the secretion of insulin-like peptides through
cyclic GMP and G-protein-coupled receptor signaling path-
ways [3,13]. Ablation of specific gustatory and olfactory
neurons results in increased lifespan, consistent with a role
for insulin/IGF-1 signaling in antagonizing longevity [4].
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Yeast Worms Flies Mammals
– INS-1–391, DAF-28 DILP-1– DILP-7 Insulin and insulin-like growth factor (IGF-1)
– DAF-2 dINR Insulin receptor (IR)/insulin-like growth factor-1 receptor (IGF-1R)
– IST-1 CHICO Insulin-receptor substrate (IRS)
– AGE-1 Dp110 Phosphoinositide 3-kinase catalytic subunit (p110)
– AAP-1 p60 Phosphoinositide 3-kinase adaptor subunit (p55)
TEP1 DAF-18 dPTEN Phosphatase and tensin homolog (PTEN)
PKH1/PKH2 PDK-1 Pk61 Phosphoinositide-dependent kinase-1 (PDK-1)
SCH9 AKT-1/AKT-2 dAKT Protein kinase B/AKT
YPK1/YKR2 SGK-12 – Serum and glucocorticoid kinase (SGK)
RTS1 PPTR-1 Widerborst Protein phosphatase 2A regulatory subunit B56b
FKH1/FKH2/FHL1/HCM1 DAF-16 dFOXO Forkhead box O (FOXO) FOXO1, FOXO3a, FOXO4, FOXO6
TOR1 LET-363 TOR Target of rapamycin (TOR)
SCH9 RSKS-1 dS6K Ribosomal S6 kinase (S6K)
KOG1P DAF-15 Raptor RAPTOR (regulatory associated protein of TOR)
AVO3 RICT-13 Rictor RICTOR (rapamycin-insensitive component of TOR)
HSF HSF-1 HSF1–4 Heat shock factor (HSF)
KEL1/KEL2/KEL3 HCF-1 dHCF Host cell factor (HCF)
SNF1 AAK-2 SNF1A AMP-dependent protein kinase (AMPK)
PSY2 SMK-1 Falafel Suppressor of Mek-1 (SMEK-1)
SPS1/STE20 CST-1 Hippo Mammalian Ste20-like kinase-1 (MST-1)
– BAR-1 Armadillo b-catenin
SIR2 SIR-2.1 SIR2 Sirtuin1–7 (SIRT)
HOG1 JNK-1 Basket c-Jun N-terminal kinase (JNK)
– SKN-1 Nrf-2 NF-E2-related factor (Nrf-2)
– – Keap-1 Kelch-like ECH-associated protein 1 (KEAP-1)
FKH1/FKH2/FHL1/HCM1 PHA-4 Fkh Forkhead transciption factor box A (Foxa)
COQ7 CLK-1 dCLK-1 Clock-1 (mCLK-1)
Arrows indicate the effect of mutations or RNAi on organismal lifespan in wild-type animals: upwards arrow, increased lifespan; downwards arrow,
decreased lifespan. 1Not all ins genes have been characterized: ins-1 mutants are short-lived, ins-7 and daf-28 mutants show an extension in lifespan
and ins-18 RNAi/mutants show both phenotypes. 2 sgk-1 lifespan data are currently conflicting. 3 rict-1 mutants show increased lifespan on HB101 bacteria
but not OP50 bacteria.Similarly, studies in flies show that ablation of neurosecre-
tory cells expressing Drosophila insulin-like peptide (dilp)
results in a 10–33% increase in median lifespan [10]. The
C. elegans genome has an astounding 40 insulin-like (ins)
genes [17,18] (http://www.wormbase.org/ WS198), and
Drosophila has 7 insulin-like peptides (dilp) [10]. Why lower
organisms appear to have such an expanded family of insu-
lins in comparison to mammals is still not entirely understood.
Although the precise ligand that binds to DAF-2 is still
unknown, studies on insulins in C. elegans revealed that
potential ligands may function either as antagonists (ins-1),
agonists (ins-7, daf-28), or both (ins-18) [19]. While most
studies on insulins in C. elegans have been genetic analyses,
one study reported biochemical verification of INS-6 binding
to the human insulin receptor [20]. The in vivo or in vitro
binding of C. elegans insulins to DAF-2 therefore has yet
to be validated. Studies in Drosophila have characterized
dilp2, dilp3 and dilp5 as important regulators of growth and
energy metabolism [10]. Many of these insulins in both
worms and flies are expressed in distinct tissues, such as
the intestine and muscle, and thus in simpler organisms
these ligands may concertedly regulate a neuroendocrine
signaling axis modulating development, metabolism, and
longevity.
Insulin/IGF-1 Receptor
Although C. elegans and Drosophila contain a multitude of
potential ligands, only a single receptor that bears homology
to the insulin and the IGF-1 receptors has been identified in
both organisms: DAF-2 in C. elegans and insulin/IGF-1 re-
ceptor (dInR) in Drosophila [10,19]. Reduction-of-function
mutations in daf-2 result in lifespan extension ranging from60–100%, indicating that under normal signaling conditions,
insulin/IGF-1 signaling promotes growth and development
while antagonizing longevity [21,22]. dInR homozygous
mutant flies are not viable; however, heteroallelic female flies
live up to 85% longer than their wild-type counterparts [6,23].
Downstream of dInR, mutations in the fly homolog of the
insulin-receptor substrate (IRS) chico also extend lifespan
up to 48% [10].
In mammals, although the insulin and IGF-1 receptors share
high homology, they modulate distinct processes, such as
metabolism and growth, respectively. Deregulation of insulin
signaling in humans leads to the onset of age-associated
debilitating diseases, for example type 2 diabetes and cancer.
Insulin-receptor knockout mice have a drastically shortened
lifespan due to ketoacidosis [24]. Studies using tissue-specific
insulin-receptorknockout micereveala morecomplexpicture,
however; fat-specific insulin receptor knockout mice not only
live almost 20% longer than control littermates, but also are
leaner, have increased insulin sensitivity, and express normal
IGF-1 levels [24]. Downstream of the receptor, there is conflict-
ing evidence about whether mice heterozygous for brain-
specific IRS2 have an increased lifespan (reviewed in [10]).
Several mammalian studies have shown that alterations to
the IGF-1–growth hormone (GH) axis can increase longevity
[6,24]. Mice bearing a mutation in the gene encoding GH and
mice with mutation in either Prop-1 or Pit-1 (transcription
factors involved in pituitary development) show enhanced
longevity compared with wild-type littermates [6]. These
long-lived mice lack several hormones, including prolactin
and thyroid-stimulating hormone, and have diminished levels
of GH and neuropeptide Y [24]. Furthermore, mice lacking
GH receptor, GH-receptor-binding protein, or GH-releasing
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Figure 1. Interactions between components of the
insulin/IGF signaling and the TOR pathways.
The insulin/IGF-1 signaling (red ovals) and TOR
(beige ovals) pathways may interact at multiple
levels to ultimately regulate organismal lifespan.
Dual coloring indicates proteins implicated in
both pathways. White ovals are proteins that are
not typically viewed as being in one pathway or
the other. The proteins are labeled with the worm
name followed by the mammalian name.
hormone receptor show increased lifespan
[6]. Interestingly, plasma IGF-1 levels are
dramatically low in all of these long-lived
mutant mice [25]. In dogs, a polymorphism
in IGF-1 is a major determinant of size and
a dog’s size is inversely correlated with life-
span [26,27]. In humans, a specific poly-
morphism in the IGF-1 receptor has been
associated with increased longevity [15].
Taken together, these data suggest that
modifying either insulin receptor or IGF-1
receptor activity can result in changes in
longevity across phylogeny.
Downstream Kinases
Similar to the signaling pathways in mam-
mals, C. elegans has a well-conserved
PI 3-kinase signaling pathway downstream
of daf-2 and age-1, the worm homolog of
the PI 3-kinase catalytic subunit (Figure 1,
Table 1) [2]. Downstream components,
such as phosphoinositide-dependent pro-
tein kinase-1 (pdk-1), akt-1, akt-2 and serum
and glucocorticoid-inducible kinase (sgk-1),
were identified by both forward and re-
verse genetic approaches, and mutations
in these genes result in lifespan extension
(Figure 1 and Table 1) [2,6]. In the budding
yeast Saccharomyces cerevisiae, in which
many aging studies have been performed,
it is not clear whether a conserved insulin/
IGF-1 pathway exists, although the con-
served Akt homolog SCH9 is important for regulating
lifespan [28].
Remarkably, reduction-of-function mutations in the
insulin/IGF-1 signaling pathway not only confer increased
longevity but also enhance resistance to heat and/or oxida-
tive stress. Studies in C. elegans revealed that these pheno-
types ultimately depend upon the single forkhead box O
(FOXO) transcription factor daf-16 [3,4,13]. Loss-of-function
mutations in daf-16 result in a dramatic suppression of the
lifespan extension and stress resistance phenotypes of
daf-2 mutants [3]. The insulin/IGF-1 signaling pathway acti-
vates AKT-1/2 and SGK-1 in a PI 3-kinase-dependent
manner, and in turn, AKT-1/2 and SGK-1 negatively regulate
DAF-16 by phosphorylation [2,4]. Under these conditions,
DAF-16 is sequestered in the cytosol by its association
with 14-3-3 proteins [8,13]. This regulation is conserved,
because mammalian AKT and SGK also directly phosphory-
late and negatively regulate FOXO proteins [29]. However,
under low signaling conditions or in loss-of-function kinase
mutants, such as daf-2 and age-1, DAF-16 is able to
translocate to the nucleus to transactivate or repress its
target genes [2,4,29].
DAF-16/FOXO
What are the important target genes that DAF-16 regulates to
confer significant increases in lifespan and stress resis-
tance? A combination of approaches, including genome-
wide screens, microarrays, and chromatin immunoprecipita-
tion, has identified hundreds of genes that are under the
control of DAF-16 [2–4,30], such as genes encoding
molecular chaperones, superoxide dismutases, metabolic
regulators, and regulators of the cell cycle. It is still unclear
how DAF-16 regulates the activity of so many genes and
whether all or a subset of these genes actively regulate the
phenotypes mentioned above. As a transcription factor,
DAF-16 may interact with other co-regulators, such as co-
activators and repressors, to define particular biological
processes. Indeed, the nuclear factor SMK-1, the C. elegans
homolog of suppressor of MEK-1 (SMEK-1), associates with
DAF-16 and is required for longevity, innate immunity and
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[2,19].
Several other additional transcription factors and co-acti-
vators (heat shock factor 1 (HSF-1), host cell factor 1 (HCF-1),
the MST-1 homolog CST-1, and the b-catenin homolog BAR-
1) have been shown or suggested to interact with DAF-16 in
the insulin/IGF-1 signaling pathway (Table 1). The transcrip-
tion factor heat-shock factor 1 (HSF-1) is an important regu-
lator of thermal stress in eukaryotes. In response to heat
stress, HSF-1 promotes the expression of heat-shock
proteins in a DAF-16-dependent manner [4]. Recently, the
C.eleganshost-cell factor homolog HCF-1 was found to asso-
ciate with DAF-16 in the nucleus and repress its transcrip-
tional activity [31]. In addition, CST-1 and BAR-1 have been
shown to regulate the transcription of genes involved in
oxidative stress in a DAF-16-dependent manner [13]. Their
respective mammalian homologs, MST-1 and b-catenin,
also interact with mammalian FOXO, thereby showing the
remarkable conservation from nematodes to higher mammals
in adaptation to oxidative stress. Thus, depending upon the
stressor, DAF-16/FOXO may not only associate with distinct
transcriptional cofactors but also regulate the transcription
of discrete sets of genes.
DAF-16 can be phosphorylated by multiple kinases at resi-
dues distinct from the AKT/SGK sites. The AMP-activated
protein kinase (AMPK) positively regulates DAF-16/FOXO
by phosphorylation [29,32]. Similarly, c-Jun terminal kinase
(JNK) phosphorylates DAF-16 and promotes its nuclear
localization, leading to increased lifespan and stress resis-
tance [3,10].
Flies also have a single FOXO homolog (dFOXO) that is
phosphorylated in response to signals transduced by dInsR.
Overexpression of dFOXO in the adult fat body results in life-
span extension [33]. Similar to worms, a JNK-dependent
increase in lifespan and stress resistance depends upon
dFOXO, and JNK and dFOXO together can negatively regu-
late insulin/IGF-1 signaling by repressing the expression of
dilp2 [10].
Much work has focused on the role of DAF-16 and dFOXO
in longevity. In mammals, there are four members of the
FOXO family that show overlapping and distinct tissue ex-
pression patterns — Foxo1, Foxo3a, Foxo4, and Foxo6 —
and their roles in longevity have not been studied [34].
Foxo1 plays an important role in angiogenesis and myoblast
and adipocyte differentiation, and Foxo1-null mutant mice
are embryonic lethal [34,35]. Foxo3a- and Foxo4-null mutant
mice are viable and grossly similar to their littermate controls,
but Foxo3a-null mutant female mice develop age-dependent
infertility [34]. Foxo6 has been shown to be expresssed in the
developing brain in embryos as well as the adult brain, and
knockout mice have not yet been examined. Although the
correlation between FOXOs and longevity has yet to be
clearly defined in mammals, these proteins have a well-es-
tablished role as tumor suppressors [34]. In addition, they
regulate the expression of stress-responsive genes, such
as manganese superoxide dismutase and Gadd45, and
may also regulate adult stem-cell proliferation [36].
To better understand the regulation of DAF-16/FOXO, it is
equally important to elucidate the proteins that modulate
insulin/IGF-1 signaling activity. While several kinases have
been well studied in mammals and in simpler organisms,
there are few known phosphatases that regulate insulin/
IGF-1 signaling in the context of longevity. The best studied
among these is daf-18, the C. elegans homolog of thephosphoinositide 3-phosphatase PTEN. Mutations in daf-18
can suppress the long lifespan of daf-2 mutants and result in
increased susceptibility to various stressors [2,11]. This
shows that, similar to its mammalian homolog, DAF-18
acts to negatively regulate PI 3-kinase signaling [2]. More
recently, the PP2A phosphatase regulatory subunit PPTR-
1/B56b was found to negatively regulate insulin/IGF-1
signaling by modulating AKT-1 phosphorylation, and thereby
positively regulating DAF-16 [37]. In contrast, the calcineurin
A serine/threonine phosphatase catalytic subunit TAX-6 and
its regulatory subunit B CNB-1 were found to be negative
regulators of insulin/IGF-1 signaling, as loss-of-function
mutants in tax-6 and cnb-1 display enhanced longevity [5].
Given that a single transcription factor downstream of
insulin/IGF-1 signaling, DAF-16, can be modulated by a multi-
tude of kinases and adaptor proteins, it is evident that this
signaling pathway is far more complex than previously
appreciated. The identification of new regulators and inter-
actors will undoubtedly shed more light on our under-
standing of how DAF-16/FOXO regulates longevity.
Dietary Restriction
Dietary restriction is a pan-species treatment that can
extend an organism’s lifespan and health [1]. While the
majority of species on restricted diets show an increased
lifespan, several species and even strains within a species
appear to be insensitive to this treatment [38]. Caloric restric-
tion, where the number of calories ingested is known, was
originally shown to result in lifespan extension more than
60 years ago. Since then, the pathways and proteins involved
in its beneficial effects have only recently been discovered.
Ins-ular View of Dietary Restriction
One attractive model is that the well-defined insulin/IGF-1
signaling pathway mediates the effects of dietary restriction.
However, current data regarding this model are not definitive.
In worms, at least six methods have been used to mimic die-
tary restriction and test its interaction with insulin/IGF-1
signaling. The effects of dietary restriction by semi-defined
media, complete starvation, or dilution of Escherichia coli in
liquid media all appear to be independent of insulin/IGF-1
signaling [7,39–41]. In contrast, dietary restriction using
mutations that limit the amount of food consumed have
both an additive and a non-additive effect with insulin/IGF-1
signaling, depending on the mutant allele [42,43]. The posi-
tive effects of dietary restriction by serial dilution of E. coli
on solid media are dependent upon DAF-16 as well as
AMPK [44]. In addition, the effects of an intermittent feeding
paradigm are partially dependent on DAF-16 but fully depen-
dent on Ras homolog enriched in brain (Rheb), a member of
the small GTPase family of proteins [9]. Thus, data generated
from studies in C. elegans generally show that the effects of
dietary restriction are independent of insulin/IGF-1 signaling,
although this depends on the method of dietary restriction.
Similar to C. elegans, the relationship between insulin/
IGF-1 signaling and dietary restriction in Drosophila is
unclear. In a study that exemplifies the importance of using
a range of levels of dietary restriction, Clancy et al. [45]
demonstrated that the lifespan of the long-lived chicomutant
is not additive to an optimized dietary restriction regimen.
These studies also showed that different strains of flies
have distinct optimal nutrient intakes (i.e. the diet restriction
level that maximally extends lifespan for one strain is not
necessarily the same for all strains). A study of dFOXO
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suggesting the opposite conclusion — that insulin/IGF-1
signaling and dietary restriction are independent pathways
[46]. One possibility for the difference could be the methods
used in these studies. Clancy et al. [45] used a diluted media-
method for dietary restriction, while Minet al. [46] reduced the
amount of yeast in the media. Therefore, as with C. elegans,
studies in Drosophila do not conclusively show whether die-
tary restriction and insulin/IGF-1 signaling are entirely inde-
pendent. These discrepancies may ultimately arise from the
different methods used to administer dietary restriction.
Limited studies have examined the interplay between in-
sulin/IGF-1 signaling and dietary restriction in mammals. In
response to caloric restriction, the long-lived Prop1 mutant
mice show a further extension in lifespan [25]. In contrast,
caloric restriction does not further increase the extended life-
span of GH receptor knockout mice [25]. Therefore, limited
conclusions can be drawn from the data on the interplay of
dietary restriction and insulin/IGF-1 signaling in mammals.
A TOR-Centric View
Of the different proteins implicated in dietary restriction, one
of the most well-characterized is the target of rapamycin
(TOR), a kinase that is part of a pathway highly conserved
from yeast to humans that functions to integrate multiple
nutrient signaling pathways [47]. As such, it is an appealing
candidate as a central regulator of the effects of dietary
restriction. TOR is active in two separate complexes contain-
ing both unique and common proteins. TOR complex 1
(TORC1) is composed of RAPTOR, PRAS40, LST8, and
TOR. TOR complex 2 (TORC2) also contains TOR and
LST8, with the additional components RICTOR, SIN1,
PROTOR [48]. (Note that the TORC2 mentioned here should
not be confused with the protein with an identical acronym
‘transducer of regulated CREB activity 2’.)
TOR — A Central Regulator of Dietary Restriction?
Evidence for a central role of the TOR pathway in dietary
restriction comes from several species. In yeast, TOR can be
required for the effects of dietary restriction [28]. In C. ele-
gans, RNAi of TOR (let-363) produces a longevity phenotype
that is independent of FOXO/DAF-16 [49]. On the other hand,
a majority of studies show that reducing TOR signaling in
dietary-restricted worms does not further increase lifespan
[50–52]. Another link between dietary restriction and TOR is
autophagy, a process by which the cell recycles its various
components. Autophagy is required for the lifespan exten-
sion effects of dietary restriction, and TOR is a central regu-
lator of this process [53–55].
As in worms [50], under normal laboratory conditions loss
of TOR or TOR complex components extends lifespan in flies
[56]. Mammalian studies linking TOR signaling and longevity
have not been published but a connection between TOR
signaling and nutrient sensing has been established. TOR
regulates food intake, and the active, phosphorylated form
of TOR is found in critical hypothalamic neurons in the arcuate
nucleus [57]. Furthermore, TOR signaling is activated by lep-
tin, a hormone released from adipose tissue in response to
increasing fat levels, and inhibition of TOR activity reduces
the anorectic effect of leptin administration [57].
Ribosomal S6 kinase (S6K), a downstream target of TOR,
mediates hunger-driven behavior in flies when upregulated
in specific neurons [58]. Further, S6K knockout mice are
resistant to diet-induced obesity and age-related obesity[59]. Therefore, under dietary restriction conditions, TOR
signaling in mammals is probably reduced and may mediate
the effects of dietary restriction, as in simpler model organ-
isms. Taken together, these studies suggest that the TOR
pathway may be the central regulator of the effects of dietary
restriction ranging from yeast to mammals.
Cross-Talk between Insulin/IGF-1 Signaling and TOR
Genetic analysis in C. elegans indicates that the insulin/IGF-1
signaling pathway and the TOR pathway are independent of or
converge downstream of DAF-16 because RNAi of TOR
increases lifespan independent ofFOXO/DAF-16, but reduced
TOR signaling does not further increase the lifespan of insulin/
IGF-1 signaling mutations [49,50]. Nevertheless, there is
a substantial amount of cross-talk between the insulin/IGF-1
signaling pathway and the TOR pathway (Figure 1). Although
both of these pathways monitor nutrients, the insulin/IGF-1
pathway is linked to an endocrine signal that monitors the
nutrient status of the whole organism, whereas the TOR
pathway monitors the intracellular nutrient status.
Insulin/IGF-1 signaling influences the TOR pathway by at
least three separate mechanisms. In worms, decreased
insulin/IGF-1 signaling inhibits the TOR pathway by reducing
the transcription of daf-15/RAPTOR [60]. Additionally, in
mammalian studies, insulin/IGF-1 signaling stimulates TOR
activity by decreasing the ability of PRAS40 and tuberous
sclerosis complex 2 (TSC2) to inhibit TORC1 (TSC2 and
tuberous sclerosis complex 1 form a complex that inhibits
Rheb-mediatedactivationofTORC1) [48]. Anotherconnection
between Rheb, TOR and insulin/IGF-1 signaling has been
shown in worms, using an intermittent feeding paradigm [9].
The TOR pathway also influences insulin/IGF-1 signaling.
In mice, TORC1 inhibits insulin/IGF-1 signaling via S6K-medi-
ated phosphorylation of IRS-1, and this is likely to be con-
served in humans [59,61]. TORC2, however, activates the
insulin/IGF-1 signaling pathway by phosphorylating AKT at
Ser473, which acts synergistically with phosphorylation by
PDK-1 at Thr308 [62,63].
In addition, AMPK directly modulates both insulin/IGF-1
and TOR signaling. In worms AMPK phosphorylates DAF-16
to increase its activity, and this effect is conserved in mam-
mals [44,64]. AMPK also phosphorylates RAPTOR and
inhibits TORC1 [65]. Moreover, by phosphorylating TSC2,
AMPK enhances the inhibitory effect of TSC2 on TOR activity
[66]. These three functions of AMPK are likely to act in concert
to strongly inhibit TOR signaling.
Insulin/IGF-1 and TOR also have several common down-
stream effectors. Both pathways regulate 4E-BP, an inhibitor
of translation, and SGK-1 [67–70]. For insulin/IGF-1 signaling,
SGK-1 negatively regulates DAF-16/FOXO under fed condi-
tions [68]. TOR activates SGK-1 by direct phosphorylation,
but it is unclear which TOR complex is responsible for the
phosphorylation (shown in Figure 1) [69,70], although recent
data from worms support the view that TORC2 is the complex
that interacts with SGK [71,72].
Additional Players
Other proteins have been implicated in dietary restriction
and longevity, but the pathways in which they are involved
are not as well-defined as the insulin/IGF-1 or TOR path-
ways. This section summarizes the roles of several of these
proteins: PHA-4/Foxa, SKN-1/Nrf2, and the sirtuins. In addi-
tion, the roles of odor and mitochondria in dietary-restricted
longevity are also described.
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Figure 2. Mathematical differentiation of odor
and caloric components of dietary restriction.
(A) Idealized survival curves representing
differential effects of odor and calories on life-
span. (B) Linearizedmortality rate curves of the
idealized survival curves. Lifespan changes
due to odor and calories can be mathemati-
cally differentiated. Lifespan changes that are
due to odor cause changes in the initial
mortality rate, while lifespan changes due to
caloric intake change the slope of the survival
curve. These differences may be due to
different mechanisms such as insulin/IGF-1
signaling or TOR signaling.Additional Players: SMK-1 and PHA-4
Panowski et al. [73] discovered that SMK-1 was required to
extend the lifespan of worms by dietary restriction. This
was particularly interesting because SMK-1 interacts with
DAF-16 and is required for extending the lifespan of insulin/
IGF-1 signaling mutants [74]. Because DAF-16 was not
required in the models of dietary restriction investigated by
Panowski et al. [73], they hypothesized that SMK-1 was inter-
acting with another transcription factor. RNAi studies carried
out to reveal this transcription factor led to the identification of
PHA-4, a Forkhead transcription factor box A (Foxa) protein,
and found that it is required for lifespan extension by dietary
restriction [73]. In worms, the TOR signaling pathway antago-
nizes PHA-4, and some of the effects of the TOR pathway on
lifespan require PHA-4 [75]. DAF-16 and PHA-4 have common
consensus binding sites within promoters, and the regulation
of at least two superoxide dismutases (sod-1 and sod-5)
depends upon both of these transcription factors [73].
Therefore, a complicated interaction between insulin/IGF-1
signaling, TOR signaling, and PHA-4 begins to emerge, but
because these interactions have only been shown in worms,
confirmation in other organisms is still required.
Additional Players: SKN-1/Nrf2
SKN-1, the worm homologue of mammalian Nrf2, is required
for lifespan extension by dietary restriction [7]. Nrf2 is
involved in the cellular response to toxins, and many studies
in mice have examined its requirement in defending against
oxidative, inflammatory, and electrophilic toxins [76]. skn-1
has a critical role in insulin/IGF-1 signaling [77]. The insulin/
IGF-1 signaling pathway directly inhibits SKN-1, suggesting
that SKN-1 may function as another point of intersection
between the insulin/IGF-1 signaling pathway and dietary
restriction [77]. It is possible that SKN-1 is important for
longevity mediated by either dietary restriction or insulin/IGF-
1 signaling, depending upon the tissue in which it isexpressed.
The role of skn-1 homologs in lifespan extension so far
appears to be conserved in simpler model organisms but
not in mammalian models. A mutation in the skn-1 repressor,
keap-1, can extend the lifespan of male flies [78]. However,
recent studies showed that Nrf2 plays no role in dietary-
restriction-induced longevity in mice, despite the mice
having a higher susceptibility to tumors [79]. Given the role
of Nrf2 in detoxification, the observed effects on lifespan
extension could also be explained if normal experimental
conditions are slightly toxic to Drosophila or C. elegans. In
fact, the E. coli that worms routinely feed on eventually infectthe worms as they age and also produce small quantities of
cyanide [80,81].
Additional Players: Sirtuins
The sirtuins (SIRT1–7) are another family of proteins that
have been implicated in dietary restriction and longevity.
Sirtuins are a highly conserved group of NAD+-dependent
de-acetylases and this dependence on NAD+ suggests that
they may be possible mediators of dietary restriction.
(NADH has been suggested to be more important to nutrient
sensing than ATP, and moreover, AMPK activity does not
significantly change in several tissues of dietary-restricted
mice [82,83].) Interestingly, lifespan extension mediated by
the C. elegans SIRT1 ortholog sir-2.1 depends upon daf-16
[84], and SIRT1 and SIRT2 deacetylate FOXO3a in mamma-
lian cell culture [84,85].
Thus far, the literature has been equivocal as to the
requirement of sirtuins for dietary restriction. In yeast, sir-
tuins are required in some strains but unnecessary in others
[8]. In worms, the requirement of sir-2.1 for lifespan exten-
sion by dietary restriction depends on the method of dietary
restriction [86]. The Drosophila ortholog of SIRT1 (dSIR2) is
required for the effects of dietary restriction [8]. Mammalian
studies are underway, but initial papers show that sirtuins
are required for some of the physiological changes associ-
ated with dietary restriction [87,88].
Two studies with Sirt1 knockout mice indicate that SIRT1
may be involved indietary restriction-mediated lifespanexten-
sion. However, these results are complicated by the fact that
Sirt1 knockout mice are short-lived [88,89]. Other studies in
mice have correlated the effects of dietary restriction with
changes in sirtuin function. Caloric restriction induces Sirt1
expression and SIRT1 nuclear localization [90,91]. Therefore,
SIR-2 and its homologs may mediate cross-talk between
dietary restriction and insulin/IGF-1 signaling.
Additional Players: Odor
In worms and flies, the smell of food alone can abolish the
life-extending effect of dietary restriction [92,93]. Mutations
in the odor receptors of worms result in lifespan extension
that is mainly dependent on DAF-16 [94]. These studies
suggest that the majority of the effects of dietary restriction
may be due to the lack of an odorant or sensation of odor.
An interesting possibility supported by mathematical anal-
ysis of dietary restriction in different species is that dietary
restriction can be broken down into two mechanisms (Fig-
ure 2) [95]. The first is dominated by insulin/IGF-1 signaling
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Figure 3. Mitochondrial signaling may me-
diate the cross-talk between the insulin/
IGF-1 signaling and TOR pathways to regulate
longevity.
Mitochondria are known to signal to the
nucleus by at least two mechanisms: one is
the retrograde signaling pathway (RTG) that
involves LST8 and possibly TOR; the other
uses reactive oxygen species and signals
through the JNK–FOXO pathway. AMPK also
receives input from mitochondria and is yet
another protein involved in the mitochondrial
control of lifespan.
and linked to odor and the anticipation
of food by the whole organism. (In fact
the mere anticipation of food can cause
an insulin release in rats and humans
[96,97].) The second is independent of
insulin/IGF-1 signaling and is instead
dependent on caloric intake and pos-
sibly regulated by the TOR pathway.
These two mechanisms are not mutu-
ally exclusive and there are a number
of different ways in which these mecha-
nisms could interact.
In worms, initial starvation causes DAF-16 to localize to the
nucleus to induce a pro-survival pathway, but, as the starva-
tion continues, DAF-16 is less nuclear and is observed in the
cytoplasm [98]. Although DAF-16 is no longer found in the
nucleus, the worms are nonetheless still resistant to free-
radical damage. Furthermore, in the same study, it was
observed that there is both DAF-16-dependent and DAF-
16-independent resistance to free-radical damage ([98] and
D. Weinkove, personal communication). Consistent with this
view, complete removal of food can extend lifespan indepen-
dent of DAF-16 [39,40]. It is plausible that the DAF-16-inde-
pendent increase in lifespan is due to decreased TOR
signaling or another yet unidentified pathway.
Additional Players: Mitochondria
Both caloric restriction and insulin affect mitochondrial
metabolism [99,100]. On their own, specific mitochondrial
mutations increase the lifespan of both worms and mice
[42,101]. Although it may be tempting to think that the
increased lifespan associated with these mitochondrial
mutations is a result of decreased metabolism, metabolic
rate does not determine lifespan [102].
It is currently unknown how mitochondrial mutations
increase lifespan but mitochondria are known to signal to
the nucleus through several possible pathways. One of the
best established pathways is the mitochondrial retrograde
signaling pathway [103,104]: this pathway has been primarily
investigated in yeast and allows the mitochondria to signal to
the nucleus [103]. LST8, a highly conserved member of both
TOR complexes (TORC1 and TORC2), has been implicated in
the regulation of this retrograde signaling pathway; further-
more, TOR signaling also regulates mitochondrial metabo-
lism [103,105]. Although it seems likely that mitochondrial
mutations signal through the retrograde signaling pathway,
the effect of this pathway on lifespan has yet to be directly
tested.
In C. elegans, the increased lifespan of two mitochondrial
mutants can be partially reduced by a mutation in AMPK
[106], but decreased ATP levels alone are not sufficient to
increase lifespan [107]. InDrosophila,mitochondrial dysfunc-
tion signals to the nucleus via two mechanisms:one mediated
by reactive oxygen species (ROS) and the other, similar to
C. elegans, mediated by AMPK [108]. While the pathway
mediated by ROS is controlled by FOXO and JNK, which
implicates the insulin/IGF-1 signaling pathway, the AMPK-
dependent pathway has implications for both insulin/IGF-1
and TOR signaling. Although this experiment did not test
the effect of these pathways on lifespan, these data are in
agreement with results from a number of longevity experi-
ments in different species that show the role of mitochondrial
components in modulating lifespan [109,110].
Studies in mice with a mitochondrial mutation in Mclk1, the
mammalian homologue of the C. elegans clk-1 gene (which
encodes a protein involved in ubiquinone synthesis that
reduces the flow of electrons in the electron transport chain
[109]), have shown that this mutation increases the lifespan
of heterozygous mice (homozygous mice are inviable)
[110]. The heterozygous, long-lived mice have decreased
ATP levels and decreased cytoplasmic ROS damage but
increased signs of mitochondrial ROS damage [110].
Further supporting the importance of ROS signaling from
the mitochondria, overexpression of the mitochondrial SOD,
Mn-SOD, increases lifespan by approximately 20% in flies
[111]. Although an increase in Mn-SOD could decrease mito-
chondrial free radicals, there were no detectable changes in
markers of free-radical stress or the ability to resist free
radical stress. A microarray analysis found a pattern sugges-
tive of both hydrogen peroxide signaling from the mitochon-
dria and decreased insulin signaling. In another study,
glucose deprivation through the use of 2-deoxy-D-glucose (a
non-metabolizable form of glucose) increased lifespan and
stress resistance in worms [112]. The addition of antioxidants
actually decreased the lifespan and suggested an important
role of oxidative stress in the observed lifespan extension.
It is still unclear whether the lifespan extension seen in
several mitochondrial mutants, such as clk-1 and the iron
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pathway [113–115]. Together, the mitochondrial studies sug-
gest the following possible scenario (Figure 3): mitochondrial
dysfunction signals to the nucleus through a number of path-
ways; sub-lethal increases of ROS in the mitochondria signal
through a JNK–FOXO pathway and extend lifespan; a second
signal involves decreased AMP levels combined with another
signal that may increase lifespan by a FOXO-independent
pathway, possibly the retrograde signaling pathway, which
may include TOR. Comprehensive experiments directly
testing this hypothesis have not yet been conducted.
Conclusions
Both insulin/IGF-1 signaling and dietary restriction can
increase lifespan in a number of different species. Addition-
ally, these events are linked by their involvement in the nutri-
tional status of the organism. Numerous studies have shown
that these lifespan-extending methods may interact at
several different levels. We suggest that the insulin/IGF-1
pathway and the pathway that mediates the effects of dietary
restriction have evolved to respond to the nutritional status
of an organism, which in turn impacts its lifespan. From an
evolutionary point of view, these longevity pathways are
likely to be used by an organism to survive unfavorable
conditions in an effort to reproduce at a later time and should
probably be more appropriately called survival pathways.
Therefore, the lifespan extension is likely to be only a by-
product of the primary function of these pathways. Several
conditions, such as a decrease in nutrient availability or
change in temperature, may cause a survival pathway to
be activated. This requires that survival pathways monitor
both external environment and internal homeostasis. Be-
cause the basic needs of most organisms are the same,
survival pathways are largely conserved. Monitoring nutrient
availability is therefore a central theme in most of these life-
span-regulating pathways. This is not surprising because the
need to regulate nutritional status is surpassed only by the
need for oxygen (in aerobic organisms) and the need for
water. Studies using complex model organisms demon-
strate the importance of endocrine signaling, but ultimately
endocrine signaling is controlled at the cellular level. The
feedback loops and intertwined nature of current studies of
insulin/IGF-1 and TOR signaling are indicative of the need
to regulate food and nutrition on multiple levels. The control
of nutritional status on a number of different levels allows for
many opportunities to manipulate this survival system,
which may not only increase lifespan but may improve over-
all health.
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